Literature DB >> 12711025

Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers.

Axel Urhausen1, Albers Torsten, Kindermann Wilfried.   

Abstract

BACKGROUND: In contrast to the acute effects of anabolic-androgenic steroid (AAS) abuse, the long-term risk profile of former long-term abusers (ExA) is less clear.
METHODS: Blood parameters of 32 male bodybuilders and powerlifters were studied. Fifteen ExA had not been abusing AAS for at least 12-43 months on average (mean dosage 700 mg for 26 weeks per year over 9 years), 17 athletes (A) were still abusing AAS (750 mg for 33 weeks per 8 years).
FINDINGS: Hemoglobin (+5%), leucocytes (+33%) and platelets (+38%) were significantly higher in A. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were higher, cholinesterase activity (CHE) lower in A (65+/-55, 38+/-27 and 3719+/-1528U/l) compared to ExA (24+/-10, 18+/-11 and 6345+/-975U/l; each P<0.001) with normal values for gamma-glutamyl transpeptidase (gamma-GT) and bilirubin. ALT, AST and CHE correlated significantly with the extent (duration and weekly dosage, expressed as a point score) of AAS abuse in A (r=0.68, 0.57 and -0.62; each P<0.01). Total and LDL-cholesterol were similar, HDL-cholesterol was distinctly lower in A than in ExA (17+/-11 and 43+/-11 mg/dl; P<0.001) and correlated negatively with the extent of AAS abuse (r=-0.50; P<0.05). Testosterone and estradiol were significantly higher, while LH, FSH and the sexual-hormone-binding (SHB) protein were lower in A than in ExA (each P<0.001). Two ExA had testosterone levels below the normal range.
INTERPRETATION: The alterations in cell counts, HDL-cholesterol, liver function and most hormones of the pituitary-testicular axis induced by a long-term abuse of AAS were reversible after stopping the medication for over 1 year. In some ExA, an increased ALT activity and a depressed testosterone synthesis were found.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711025     DOI: 10.1016/s0960-0760(03)00105-5

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  14 in total

1.  Influence of nandrolone decanoate administration on serum lipids and liver enzymes in rats.

Authors:  Mohammad Reza Samieinasab; Mohammad Reza Shahraki; Fatemah Samieinasab; Somayeh Najafi
Journal:  ARYA Atheroscler       Date:  2015-07

Review 2.  Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm.

Authors:  Suraj Achar; Armand Rostamian; Sanjiv M Narayan
Journal:  Am J Cardiol       Date:  2010-09-15       Impact factor: 2.778

Review 3.  Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications.

Authors:  Gen Kanayama; Kirk J Brower; Ruth I Wood; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2010-02-25       Impact factor: 4.492

Review 4.  Hematological changes during androgen deprivation therapy.

Authors:  Mathis Grossmann; Jeffrey D Zajac
Journal:  Asian J Androl       Date:  2012-01-09       Impact factor: 3.285

5.  Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.

Authors:  Gen Kanayama; James I Hudson; James DeLuca; Stephanie Isaacs; Aaron Baggish; Rory Weiner; Shalender Bhasin; Harrison G Pope
Journal:  Addiction       Date:  2015-02-25       Impact factor: 6.526

Review 6.  Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.

Authors:  Maria A Christou; Panagiota A Christou; Georgios Markozannes; Agathocles Tsatsoulis; George Mastorakos; Stelios Tigas
Journal:  Sports Med       Date:  2017-09       Impact factor: 11.136

7.  Serum testosterone level and related metabolic factors in men over 70 years old.

Authors:  Y-J Tang; W-J Lee; Y-T Chen; P-H Liu; M-C Lee; W H H Sheu
Journal:  J Endocrinol Invest       Date:  2007-06       Impact factor: 4.256

8.  Chronic Exercise Reduces CETP and Mesterolone Treatment Counteracts Exercise Benefits on Plasma Lipoproteins Profile: Studies in Transgenic Mice.

Authors:  Andrea Camargo Casquero; Jairo Augusto Berti; Laura Lauand Sampaio Teixeira; Helena Coutinho Franco de Oliveira
Journal:  Lipids       Date:  2017-10-20       Impact factor: 1.880

9.  Boldenone Undecylenate-Mediated Hepatorenal Impairment by Oxidative Damage and Dysregulation of Heat Shock Protein 90 and Androgen Receptors Expressions: Vitamin C Preventive Role.

Authors:  Amany Behairy; Wafaa A M Mohamed; Lamiaa L M Ebraheim; Mohamed Mohamed Soliman; Yasmina M Abd-Elhakim; Nabela I El-Sharkawy; Taghred M Saber; Maha M El Deib
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

10.  Alpinia: the gold mine of future therapeutics.

Authors:  S Ghosh; L Rangan
Journal:  3 Biotech       Date:  2012-09-18       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.